nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
|
Luining, Wietske I. |
|
|
8 |
3 |
p. 632-640 |
artikel |
2 |
American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive Radiotherapy
|
Valle, Luca F. |
|
|
8 |
3 |
p. 796-804 |
artikel |
3 |
A Nationwide Real-world Evaluation of Upfront Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma in the Immunotherapy Era
|
Yildirim, Hilin |
|
|
8 |
3 |
p. 623-631 |
artikel |
4 |
Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology Guidelines
|
Rai, Bhavan Prasad |
|
|
8 |
3 |
p. 841-852 |
artikel |
5 |
Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST Project
|
Masson-Lecomte, Alexandra |
|
|
8 |
3 |
p. 603-607 |
artikel |
6 |
Circulating Tumor DNA: A New Research Frontier in Urological Oncology from Localized to Metastatic Disease
|
Garofoli, Marianna |
|
|
8 |
3 |
p. 805-817 |
artikel |
7 |
Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer
|
Agrawal, Raag |
|
|
8 |
3 |
p. 716-730 |
artikel |
8 |
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer
|
Ravi, Praful |
|
|
8 |
3 |
p. 709-715 |
artikel |
9 |
Contents
|
|
|
|
8 |
3 |
p. iii-viii |
artikel |
10 |
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216
|
Swami, Umang |
|
|
8 |
3 |
p. 612-615 |
artikel |
11 |
Cost-effectiveness Analysis in the New Era of Treatment Strategies in Metastatic Urothelial Carcinoma Based on Checkmate-901 and EV302/Keynote-A39
|
Rieger, Constantin |
|
|
8 |
3 |
p. 681-688 |
artikel |
12 |
Cost-utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care
|
Lindsay, Daniel |
|
|
8 |
3 |
p. 674-680 |
artikel |
13 |
Digital Pathology–based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer
|
Markowski, Mark C. |
|
|
8 |
3 |
p. 755-762 |
artikel |
14 |
Early Oncological Outcomes in Patients who Underwent Staging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging Before Radical Prostatectomy and Extended Pelvic Lymph Node Dissection
|
Ettema, Rosemarijn H. |
|
|
8 |
3 |
p. 739-746 |
artikel |
15 |
Editorial Board
|
|
|
|
8 |
3 |
p. i-ii |
artikel |
16 |
Hall of Fame
|
|
|
|
8 |
3 |
p. ix |
artikel |
17 |
Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the European Association of Urology Renal Cell Carcinoma Guidelines Panel
|
Marconi, Lorenzo |
|
|
8 |
3 |
p. 616-622 |
artikel |
18 |
Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review
|
van den Brink, Luna |
|
|
8 |
3 |
p. 829-840 |
artikel |
19 |
Patients’ Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study
|
Connor, Martin J. |
|
|
8 |
3 |
p. 663-673 |
artikel |
20 |
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
|
Yu, Evan Y. |
|
|
8 |
3 |
p. 641-651 |
artikel |
21 |
Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature
|
Heidegger, Isabel |
|
|
8 |
3 |
p. 652-662 |
artikel |
22 |
Re: Bertrand F. Tombal, Francisco Gomez-Veiga, Alvaro Gomez-Ferrer, et al. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). Eur Urol Oncol 2024;7:1051–60
|
Montorsi, Francesco |
|
|
8 |
3 |
p. 856 |
artikel |
23 |
Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer
|
Zacchi, Francesca |
|
|
8 |
3 |
p. 818-828 |
artikel |
24 |
Reducing Overtreatment of Prostate Cancer Patients: Revisiting the European Association of Urology Pretreatment Risk Group Classification Using Long-term Follow-up Data from the European Randomized Study of Screening for Prostate Cancer Rotterdam
|
de Vos, Ivo I. |
|
|
8 |
3 |
p. 747-754 |
artikel |
25 |
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti’s Letter to the Editor re: Bertrand F. Tombal, Francisco Gomez-Veiga, Alvaro Gomez-Ferrer, et al. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). Eur Urol Oncol 2024;7:1051–60
|
Tombal, Bertrand |
|
|
8 |
3 |
p. 853 |
artikel |
26 |
Reply to Ignacio Puche-Sanz, Ugo Giovanni Falagario, Giorgio Gandaglia, et al’s Letter to the Editor re: Evelien J.E. van Altena, Bernard H.E. Jansen, Marieke L. Korbee, et al. Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.09.015
|
van Altena, Evelien J.E. |
|
|
8 |
3 |
p. 854-855 |
artikel |
27 |
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series
|
Abancourt, Ludwige |
|
|
8 |
3 |
p. 774-781 |
artikel |
28 |
Sex Disparity in Non–muscle-invasive Bladder Cancer: Pitfalls of Large Population-based Data Sets and Lessons from an Integrated Analysis
|
Lobo, Niyati |
|
|
8 |
3 |
p. 608-611 |
artikel |
29 |
Stereotactic Radiation for Primary Renal Cell Carcinoma: Is It Ready for Prime Time?
|
Hannan, Raquibul |
|
|
8 |
3 |
p. 597-600 |
artikel |
30 |
Suffering in Silence: Loneliness Among Men with Prostate Cancer and the Potential for Exercise as Connection
|
Winters-Stone, Kerri |
|
|
8 |
3 |
p. 792-795 |
artikel |
31 |
The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy
|
Soeterik, Timo F.W. |
|
|
8 |
3 |
p. 731-738 |
artikel |
32 |
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study
|
Buffoni, Martina |
|
|
8 |
3 |
p. 782-791 |
artikel |
33 |
Treatment of Metastatic Renal Cell Carcinoma: Lack of Consensus Urges the Need for a Well-organized Multidisciplinary Team
|
Muselaers, Stijn |
|
|
8 |
3 |
p. 601-602 |
artikel |
34 |
Treatment Response Assessment According to Updated PROMISE Criteria in Patients with Metastatic Prostate Cancer Using an Automated Imaging Platform for Identification, Measurement, and Temporal Tracking of Disease
|
Benitez, Cecil M. |
|
|
8 |
3 |
p. 700-708 |
artikel |
35 |
Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials
|
Udovicich, Cristian |
|
|
8 |
3 |
p. 763-773 |
artikel |
36 |
Value of Whole-body Magnetic Resonance Imaging Using the MET-RADS-P Criteria for Assessing the Response to Intensified Androgen Deprivation Therapy in Metastatic Hormone-naïve and Castration-resistant Prostate Cancer
|
Van Damme, Julien |
|
|
8 |
3 |
p. 689-699 |
artikel |